Skip to main content
Clinical Trials/ITMCTR2000003253
ITMCTR2000003253
Not Yet Recruiting
Phase 1

The clinical effect and biomechanical mechanisms of Peony and licorice decoction fumigation treatment for poststroke strephenopodia: a randomized controlled pilot trial

Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine
Status
Not Yet Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. confirmed stroke patients with results from computed tomography (CT) or magnetic resonance imaging (MRI);
  • 2\. aged between 35 and 75 years, male or female;
  • 3\. first episode of stroke or with a history of stroke but with no serious neurofunctional disablility and modified Ranking Scale (mRS) grade \<\= 2;
  • 4\. stable condition after stroke and within 6 months of the duration;
  • 5\. with strephenopodia and be able to walk at least 6 meters;
  • 6\. blood pressure lower than 160/100 mmHG;
  • 7\. sufficient cognition to follow commands and Mini\-Mental State Examination (MMSE) score \>\=24;
  • 8\. never used fumigation treatment before;
  • 9\. the patients or their legal guardian sign an informed consent.

Exclusion Criteria

  • 1\. received surgery or thrombolytic therapy;
  • 2\. duration of stroke more than 6 months;
  • 3\. stroke without strephenopodia or with but could not walk 6 meters;
  • 4\. vital signs are not stable or with worsening conditions such like new infarction or bleeding;
  • 5\. combined with other cerebral diseases such as subarachnoid hemorrhage, cerebral hemorrhage, brain tumor, brain trauma and so on;
  • 6\. combined with lumbar vertebrae disease, knee joint disease, foot disease and other diseases that can affect the patient's walking gait;
  • 7\. combined with severe dysfunction of heart, lung, liver, kidney and blood system;
  • 8\. combined with moderate to severe cognitive comprehension or visual impairment that can affet rehabilitation treatment or gait examination;
  • 9\. pregnant or lactating women;
  • 10\. participating in other clinical trials.

Outcomes

Primary Outcomes

Not specified

Similar Trials